跳至主要内容
临床试验/NCT04008446
NCT04008446已完成不适用

Effect of Vitamin B12 on the Development of Sepsis, in Culture Positive Patients : an Observational Study.

University of Zurich1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
Holotranscobalamin (HTC) levels

研究概览

简要总结

This is an prospective observational study assessing the effect of vitamin B12 on the odds of developing sepsis in patients with infection confirmed by a positive culture result.

The hypothesis is that patients with infection confirmed by positive cultures who develop sepsis have lower vitamin B12 levels than patients infection, confirmed by positive cultures, who do not develop sepsis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (≥18 years old)
  • Infection, confirmed by a positive culture result
  • Signed informed consent.

排除标准

  • Pregnancy and/or breast feeding
  • Inability to follow the procedures of the study, due to language problems, psychological disorders, social conditions or dementia

结局指标

主要结局

Holotranscobalamin (HTC) levels

时间窗: 6 days

HTC levels in patients with infection and sepsis compared to patients with infection without sepsis.

次要结局

  • Vitamin B12 levels(6 days)
  • Methylmalonic acid (MMA) levels(6 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Effect of Vitamin B12 on the Development of Sepsis,... | 临床试验